Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Myears

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Comprehensive Therapy|April 1, 1989
Tissue plasminogen activator: an updateD W Myears, P A Ludbrook
The American Journal of Physiology|July 1, 1987
Substrate use in ischemic and reperfused canine myocardium: quantitative considerationsD W Myears, B E Sobel, S R Bergmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1989
Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilizationM A Brown, D W Myears, S R Bergmann
Journal of the American College of Cardiology|October 1, 1988
Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomographyM A Brown, D W Myears, S R Bergmann
Journal of the American College of Cardiology|October 1, 1989
Optimal criteria for rapid detection of myocardial reperfusion by creatine kinase MM isoforms in the presence of residual high grade coronary stenosisR Nohara, D W Myears, B E Sobel, et al.
The Laryngoscope|October 1, 1985
Functional versus organic vocal cord paralysis: rapid diagnosis and decannulationD W Myears, R J Martin, R C Eckert, et al.
Journal of the American College of Cardiology|May 1, 1988
Compromise of beneficial effects of reperfusion on myocardium supplied by vessels with critical residual stenosisD W Myears, R Nohara, D R Abendschein, et al.
Circulation|June 1, 1987
Intramuscular administration of human tissue-type plasminogen activator in rabbits and dogs and its implications for coronary thrombolysisB E Sobel, J E Saffitz, L E Fields, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Comprehensive Therapy|April 1, 1989
Tissue plasminogen activator: an updateD W Myears, P A Ludbrook
The American Journal of Physiology|July 1, 1987
Substrate use in ischemic and reperfused canine myocardium: quantitative considerationsD W Myears, B E Sobel, S R Bergmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1989
Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilizationM A Brown, D W Myears, S R Bergmann
Journal of the American College of Cardiology|October 1, 1988
Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomographyM A Brown, D W Myears, S R Bergmann
Journal of the American College of Cardiology|October 1, 1989
Optimal criteria for rapid detection of myocardial reperfusion by creatine kinase MM isoforms in the presence of residual high grade coronary stenosisR Nohara, D W Myears, B E Sobel, et al.
The Laryngoscope|October 1, 1985
Functional versus organic vocal cord paralysis: rapid diagnosis and decannulationD W Myears, R J Martin, R C Eckert, et al.
Journal of the American College of Cardiology|May 1, 1988
Compromise of beneficial effects of reperfusion on myocardium supplied by vessels with critical residual stenosisD W Myears, R Nohara, D R Abendschein, et al.
Circulation|June 1, 1987
Intramuscular administration of human tissue-type plasminogen activator in rabbits and dogs and its implications for coronary thrombolysisB E Sobel, J E Saffitz, L E Fields, et al.
Pageof 1